Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-26 @ 1:10 PM
Study NCT ID:
NCT04924192
Status:
UNKNOWN
Last Update Posted:
2021-09-21
First Post:
2021-06-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study of TQB3616 Capsules Combined With Anlotinib Hydrochloride Capsules or Standard Chemotherapy Second-line and Above in the Treatment of Advanced Lung Cancer
Sponsor:
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-08-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-10
First Submit QC Date:
None
Study First Post Date:
2021-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-18
Last Update Post Date:
2021-09-21
Last Update Post Date Type:
ACTUAL